Efficacy of cabergoline in restless legs syndrome: A placebo-controlled study with polysomnography (CATOR)

Neurology

Volumn 67, Issue 6, 2006, Pages 1040-1046

  Oertel, W H ^a   Benes H ^b   Bodenschatz, R ^c   Peglau, I ^c   Warmuth, R ^c   Happe, S ^d   Geisler, P ^e   Cassel, W ^a   Leroux, M ^f   Kohnen, R ^a,g   Stiasny Kolster, K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Sleep Medicine Schwerin Ltd   (Germany)

^c University Goettingen ^*

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f PFIZER INC   (United States)

^g IMEREM Institute for Medical Research Management and Biometrics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE;

ADULT; AGED; AROUSAL; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; NAUSEA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SENSORIMOTOR FUNCTION; SHORT COURSE THERAPY; SLEEP DISORDER; SLEEP TIME; STOMACH DISEASE; VERTIGO; VOMITING;

EID: 33749002810     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000237742.08297.22     Document Type: Article

References (36)

1. Allen R, Picchietti D, Hening W, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003;4:101-119.
2. The International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs. Sleep Med 2003;4:121-132.
3. Trenkwalder C, Stiasny K, Pollmächer T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995;18:681-688.
4. Collado-Seidel V, Kazenwadel J, Wetter TC, et al. A controlled study of additional SR-L-dopa in L-dopa responsive RLS with late night symptoms. Neurology 1999;52:285-290.
5. Benes H, Kurella B, Kummer J, et al. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomised, multi-center, crossover trial. Sleep 1999;22:1073-1081.
6. Saletu M, Anderer P, Högl B, et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm 2003;110:611-626.
7. Earley J, Yaffee JB, Allen RB. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998;51:1599-1602.
8. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-950.
9. Trenkwalder C, Hundemer HP, Lledo A, et al., on behalf of the PEARLS Study Group. A randomized long-term placebo-controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology 2004;62:1391-1397.
10. Allen R, Becker PM, Bogan R, et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004;27:907-914.
11. Happe S, Sauter C, Klosch G, Saletu B, Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003;48:82-86.
12. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
13. Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 2002;252:185-194.
14. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002;59:1573-1579.
15. Saletu M, Anderer P, Saletu-Zyhlarz G, et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001;11:153-161.
16. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-332.
17. Eisensehr I, Ehrenberg BL, Solti SR, Noachtar S. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow release levodopa/benserazid. J Neurol 2004;251:579-583.
18. Del Dotto P, Bonuccelli U. Clinical pharmacokinetics of cabergoline. Clin Pharmacokinet 2003;42:633-645.
19. Stiasny K, Roebbecke J, Schüler P, Oertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline: an open clinical trial. Sleep 2000;23:349-354.
20. Benes H, Heinrich CR, Ueberall MA, Kohnen R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 2004;27:674-682.
21. Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome (RLS). Neurology 2004;63:2272-2279.
22. Rye DB. Relief in sight for restless legs syndrome. Neurology 2004;63:2213-2214.
23. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
24. Kohnen R, Oertel WH, Stiasny-Kolster K, Benes H, Trenkwalder C. Severity rating of restless legs syndrome: validation of the RLS-6 scales. Sleep 2004;27 (suppl 1):A304. Abstract 680.
25. Lesage S, Hening WA. The restless legs syndrome and periodic limb movement disorder: a review of management. Sem Neurol 2004;24:249-259.
26. Penzel T, Brandenburg U, Peter JH, et al. A new design of a polysomnography-based multi-center treatment study for the restless legs syndrome. Clin Neurophysiol 2002;113:571-578.
27. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute, 1968.
28. Atlas Task Force of the American Sleep Disorders Association. Guilleminault C, chairman. EEG arousals: scoring rules and examples. Sleep 1992;15:173-184.
29. Atlas Task Force of the American Sleep Disorders Association. Recording and scoring leg movements. Sleep 1993;16:748-759.
30. Hening W, Allen R. Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Med 2004;4:95-97.
31. Goertelmeyer R, ed. On the development of a standardized sleep inventory for the assessment of sleep. Stuttgart/New York: Fischer, 1985.
32. Kohnen R, Benes H, Heinrich CR, Kurella B. Development of the disease-specific Restless Legs Syndrome Quality of Life (RLS-QoL) questionnaire. Mov Disord 2002;17 (suppl 5):P743.
33. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545.
34. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometric 1984;40:1079-1087.
35. Lehmacher W, Wassmer G, Reimeir P. Procedures for two-sample comparisons with multiple endpoints controlling experimentwise error rate. Biometrics 1991;47:511-521.
36. Mahowald MW. Assessment of periodic leg movements is not an essential component of an overnight sleep study. Am J Resp Crit Care Med 2001;164:1340-1341.